Aims Data on non-vitamin K antagonist oral anticoagulants (NOACs) use in patients with
atrial fibrillation (AF) and frailty are scarce. Therefore, the impact of frailty on AF-related …

Introduction Both the prevalence of atrial fibrillation (AF) and its subsequent use of direct oral
anticoagulants (DOACs) are rapidly increasing in patients of older age. In the absence of …

Reperfusion therapy in the form of intravenous thrombolysis (IVT) and endovascular
thrombectomy (EVT) has revolutionised the field of stroke medicine. Atrial fibrillation (AF) …

Abstract Background and Objective Post-stroke epilepsy represents an important clinical
challenge as it often requires both treatment with direct oral anticoagulants (DOACs) and …

Aims Although frail patients with atrial fibrillation (AF) carry a high risk of stroke and
treatment-related bleeding complications, evidence for the safety and effectiveness of …

OBJECTIVE Although oral anticoagulant use has been implicated in worse outcomes for
patients with a traumatic brain injury (TBI), prior studies have mostly examined the use of …

Aims Literature regarding anticoagulants in older people affected by atrial fibrillation (AF) is
limited to retrospective studies, poorly considering the importance of multidimensional frailty …

Atrial fibrillation (AF) prevalence increases in older patients which also show a high
thromboembolic risk. Oral anticoagulants (OACs) are recommended to prevent …

Abstract Background Oral anticoagulants (OACs) are effective in reducing the risk of
cardioembolic stroke due to atrial fibrillation. While most nursing home residents with atrial …

Introduction There is a paucity of real-world studies examining the risks of stroke/systemic
embolism (SE) and major bleeding (MB) among non-valvular atrial fibrillation (NVAF) …